CY2027 RxHCC model finalized — separate segments for MA-PD and standalone PDP. See what changed →
The RxHCC commons — an open civic space for Part D risk adjustment
The open reference layer · By CuraFi

Uncaptured RxHCC costs plans millions a year.

RxHCC is how CMS pays for prescription drug risk. It's updated every year, published in government-document form, and worth millions per plan. This site makes it usable.

Start here

RxHCC, in plain language

Every Medicare Advantage drug plan gets paid a risk score for each member. That score — the RxHCC score — comes from diagnoses, demographics, and the CY model coefficients CMS publishes annually.

Higher documented acuity, higher score, higher Direct Subsidy payment. Moving a member from 1.0 to 1.16 is worth roughly $47 PMPM — about $568 PMPY. At 2.0, the same 16% gap is worth nearly double.

CMS publishes the model software and factors every year. What it doesn't publish is a way for a normal human to use them. That's the gap this site fills.

Read: How Part D risk adjustment works →
A doorway into the RxHCC system
$568PMPY per +0.16 RxHCC (from RAF 1.0)
~$8Mleft unclaimed per 50K-member plan
600–1,200prescribers drive 80% of claims value
2027model year now finalized — new segments
Plans and providers, connected
The insight

It's not about figuring out the codes

The codes are published. The coefficients are public. The money already exists — it's allocated, actuarially justified, and waiting.

The hard part is aligning with providers to compliantly code: getting the diagnoses that already exist in the clinical record documented, coded, and submitted — with evidence that survives a RADV audit.

A typical plan's pharmacy claims concentrate in a few hundred prescribers. That's not an enterprise transformation. That's a focused, provider-aligned workflow.

How plans operationalize this →
Compliance first

Documented, or it didn't happen

Raise scores without evidence and CMS calls it upcoding. Raise them with documentation and it's revenue you already earned.

Every legitimate RxHCC improvement traces back to clinical evidence in the patient record — a full audit trail, RADV-ready by default. Greed and fear have the same answer.

Read: RxHCC audit readiness →
Documentation and audit trail
The library

Go as deep as you want

Surface explainers up front. CMS citations, model mechanics, and whitepaper-depth analysis one click in. All free, all indexable, all yours.

Explainer

How Part D risk adjustment works

RxHCC scores, Direct Subsidy mechanics, and why diagnoses become dollars.

2027 model

MA-PD risk adjustment strategy

What the finalized CY2027 segments mean for plan payment.

IRA

IRA Part D redesign liability

The redesign shifted plan liability. Here's the math.

Policy

The $2,000 out-of-pocket cap

What the cap changed about plan economics.

Mechanics

Retrospective vs. prospective RxHCC

Two operating models, one compliant revenue engine.

Operations

PA turnaround under CMS-0057-F

The 72-hour rule and what it demands operationally.

Open the full library →
FAQ

Questions, answered

What is RxHCC?

The prescription drug risk-adjustment model CMS uses to pay Part D plans. Diagnoses map to RxHCC condition categories, categories carry coefficients, hierarchies dedupe them, and the sum is a member's Rx risk score — which scales the Direct Subsidy.

What changed for CY2027?

CMS finalized substantial updates, including separate model segments for MA-PD versus standalone PDP beneficiaries, refreshed coefficients, and methodological changes. Plans need to re-model revenue exposure against the new factors.

Is this a calculator or an API?

No. RxHCC.com is a reference layer — explainers, model documentation, and analysis. The point is understanding, not tooling.

Isn't raising risk scores just upcoding?

Raising scores without clinical evidence is upcoding. Documenting acuity that already exists in the record — with a defensible evidence trail — is capturing revenue the plan already earned. The difference is documentation.

Who is CuraFi?

The team behind this reference layer. CuraFi works with MA-PD plans, ACOs, and provider networks on compliant risk adjustment, utilization management, and prior authorization — and keeps this site free.

What if we want help doing this?

One door: talk to CuraFi. Consulting, analytics, or partnership with our ACO network to improve coding, risk adjustment, and compliance.

Principles

What makes this different

Open by default

Open by default

Everything CMS publishes, translated into plain language and kept current. No login, no paywall, no sales gate on the reference layer.

Built for both sides

Built for both sides

Plans and providers reading from the same page. Risk adjustment only works when the people coding and the people paid share an understanding.

Audit-ready

Audit-ready by design

Every claim traces to clinical evidence. If it wouldn't survive a RADV audit, it doesn't belong in the submission.

Finalized · CMS
CY2027

The 2027 RxHCC model is final — separate segments for MA-PD and standalone PDP, refreshed coefficients, new methodology. Your 2026 baseline is already out of date.

Read the analysis →
Latest updates

From the library

More updates →
Aug 2026

Retrospective vs. prospective RxHCC

Two operating models for the same compliant revenue engine — and when each wins.

Aug 2026

IRA Part D redesign liability

The redesign moved real money onto plan balance sheets. The math, plainly.

Aug 2026

PA turnaround under CMS-0057-F

72 hours, no exceptions. What the rule demands from your UM operation.

Get started

Pick your on-ramp

Read the primer

Ten minutes, plain language, zero jargon. What RxHCC is and why it pays.

Start reading →

Understand 2027

What the finalized model changes, who it hits, and what to re-model first.

See the changes →

Talk to CuraFi

Consulting, analytics, or ACO network partnership. One door.

Reach out →
One door

The money already exists. Do the work to get paid.

We work with plans and provider networks to capture legitimate, documented RxHCC revenue — and survive the audit afterward. Pick a lane, or just start the conversation.

Talk to CuraFi →